JMP Securities Maintains Market Outperform on Pharvaris, Raises Price Target to $50
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Jonathan Wolleben maintains a Market Outperform rating on Pharvaris (NASDAQ:PHVS) and raises the price target from $49 to $50.
April 11, 2024 | 4:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pharvaris' price target was raised from $49 to $50 by JMP Securities, maintaining a Market Outperform rating.
The increase in price target by JMP Securities reflects a positive outlook on Pharvaris, suggesting confidence in the company's future performance. This analyst endorsement is likely to instill investor confidence, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100